Anthem Launches Voluntary Oncology Dose Reduction Program

woman-with-cancer-is-meeting-with-her-doctor-chemotherapy-treatment-is-going-well
September 9

As payers continue to search for ways to reduce their drug spend, one health plan recently rolled out a dose reduction program for some oncology therapies. Anthem Blue Cross and Blue Shield is asking providers in certain situations to “voluntarily reduce the requested dose to the nearest whole vial,” according to provider newsletters. The policy went into effect July 1.

A review of the policy in Anthem provider bulletins across various states revealed that some, such as California, are restricted to Medicare Advantage plan members, but others, such as Missouri, simply refer to “members covered by Anthem Blue Cross and Blue Shield.”

0
0 Comments
Angela Maas

Angela Maas

Angela has an extensive background of editing, reporting and writing for trade and consumer publications. She has written Radar on Specialty Pharmacy (formerly called Specialty Pharmacy News) since she joined AIS Health in 2005 and has broad knowledge of the various issues at play within the space. Before joining AIS Health, she was managing editor at Employee Benefit News and Employee Benefit News Canada and managing editor at HemAware (a hemophilia publication), Lupus Living and Momentum (a multiple sclerosis publication). She has a B.A. in English and an M.A. in British literature from Arizona State University.

Related Posts

businessman-holding-a-cellphone
January 12

More Complex Specialty Drug Management, Pandemic Pressures and Inflation Reduction Act Were Some 2022 Trends

READ MORE
fda-approved-rubber-stamp-with-fda-and-pills-on-craft-paper
January 12

New FDA Approvals: FDA Gives Accelerated Approval to Mirati’s Krazati

READ MORE
tubes
January 12

FDA Approved Four New Gene Therapies, Other Novel Agents in 2022

READ MORE
panalgo-building-an-effective-analytics-team

The Latest

Premium Categories

directory-of-health-plans-test-drive-directory-of-health-plans-ad

Meet Our Reporters

GAIN THERAPEUTIC AREA-SPECIFIC INTEL TO DRIVE ACCESS FOR YOUR BRAND

Sign up for publications to get unmatched business intelligence delivered to your inbox.

subscribe today